NVOS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NVOS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Novo Integrated Sciences's Average Total Inventories for the three months ended in May. 2024 was $1.03 Mil. Novo Integrated Sciences's Cost of Goods Sold for the three months ended in May. 2024 was $2.26 Mil. Hence, Novo Integrated Sciences's Days Inventory for the three months ended in May. 2024 was 41.66.
The historical rank and industry rank for Novo Integrated Sciences's Days Inventory or its related term are showing as below:
During the past 13 years, Novo Integrated Sciences's highest Days Inventory was 47.57. The lowest was 22.57. And the median was 32.03.
Novo Integrated Sciences's Days Inventory declined from May. 2023 (42.97) to May. 2024 (41.66).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year. Novo Integrated Sciences's Inventory Turnover for the three months ended in May. 2024 was 2.19.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Novo Integrated Sciences's Inventory-to-Revenue for the three months ended in May. 2024 was 0.33.
The historical data trend for Novo Integrated Sciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novo Integrated Sciences Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Aug17 | Aug18 | Aug19 | Aug20 | Aug21 | Aug22 | Aug23 | |||||||||||
Days Inventory | Get a 7-Day Free Trial |
![]() |
![]() |
- | - | 22.57 | 32.03 | 47.57 |
Novo Integrated Sciences Quarterly Data | ||||||||||||||||||||
Aug19 | Nov19 | Feb20 | May20 | Aug20 | Nov20 | Feb21 | May21 | Aug21 | Nov21 | Feb22 | May22 | Aug22 | Nov22 | Feb23 | May23 | Aug23 | Nov23 | Feb24 | May24 | |
Days Inventory | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
42.97 | 39.30 | 55.72 | 54.79 | 41.66 |
For the Medical Care Facilities subindustry, Novo Integrated Sciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Novo Integrated Sciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Novo Integrated Sciences's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Novo Integrated Sciences's Days Inventory for the fiscal year that ended in Aug. 2023 is calculated as
Days Inventory (A: Aug. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Aug. 2022 ) | + | Total Inventories (A: Aug. 2023 )) | / | count ) | / | Cost of Goods Sold (A: Aug. 2023 ) | * | Days in Period |
= | ( (0.879 | + | 1.107) | / | 2 ) | / | 7.619 | * | 365 |
= | 0.993 | / | 7.619 | * | 365 | ||||
= | 47.57 |
Novo Integrated Sciences's Days Inventory for the quarter that ended in May. 2024 is calculated as:
Days Inventory (Q: May. 2024 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Feb. 2024 ) | + | Total Inventories (Q: May. 2024 )) | / | count ) | / | Cost of Goods Sold (Q: May. 2024 ) | * | Days in Period |
= | ( (0.947 | + | 1.112) | / | 2 ) | / | 2.255 | * | 365 / 4 |
= | 1.0295 | / | 2.255 | * | 365 / 4 | ||||
= | 41.66 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novo Integrated Sciences (OTCPK:NVOS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Novo Integrated Sciences's Inventory Turnover for the three months ended in May. 2024 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 2.255 | / | 1.0295 | |
= | 2.19 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Novo Integrated Sciences's Inventory to Revenue for the three months ended in May. 2024 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 1.0295 | / | 3.152 | |
= | 0.33 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Novo Integrated Sciences's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Sarfaraz Ali | director | C/O NOVO INTEGRATED SCIENCES, INC.,, 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004 |
Robert Letterio Oliva | director | 115 BELFIELD RD, TORONTO A6 L0J 1C0 |
Sterling M. Jimenez | officer: Principal Financial Officer | C/O NOVO INTEGRATED SCIENCES, INC.,, 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004 |
Michael Ross Pope | director | 1045 PROGRESS CIRCLE, LAWRENCEVILLE, GEORGIA GA 30043 |
Alex Flesias | director | 41 LANDMARK COURT, UNIONVILLE A6 L3R 9N7 |
Michael Joseph Gaynor | director | 49 BALMORAL ST, KEMPTVILLE A6 K0G 1J0 |
Robert Mattacchione | director, 10 percent owner, officer: Chief Executive Officer | 79 SELVAPIANO CRES, WOODBRIDGE A6 L4H 0X1 |
Pierre Joseph Dalcourt | director, 10 percent owner | 35 BRYANT ST , BOX 2230, HEARST A6 P0L 1N0 |
Christopher Mehlin David | director, officer: President | 10425 SE 22ND ST., BELLEVUE WA 98004 |
Thomas Edward Bray | officer: Principal Financial Officer | C/O NOVO INTEGRATED SCIENCES, INC., 11120 NE 2ND STREET, SUITE 100, BELLEVUE WA 98004 |
Rebecca Aw Mcdonald | officer: Chief Accounting Officer | 1301 INTERNATIONAL SPEEDWAY BLVD., DELAND FL 32724 |
James Jr Teters | director | 1200 FLIGHTLINE BLVD, STE 5, DELAN FL 32724 |
Phyllis Rouse | officer: secretary | 1200 FLIGHLINE BLVD,, SUITE 5, DELAND FL 32724 |
Jay Hilden | officer: President & CEO | 1200 FLIGHLINE BLVD,, SUITE 5, DELAND FL 32724 |
Robert Adamo | director | 1200 FLIGHTLINE BOULEVARD, SUITE 5, DELAND FL 32724 |
From GuruFocus
By Business Wire • 12-04-2023
By Business Wire • 10-24-2023
By Business Wire • 11-03-2023
By Business Wire • 08-22-2023
By Business Wire • 10-06-2023
By Business Wire • 02-16-2024
By Business Wire • 02-21-2024
By Business Wire • 08-15-2023
By Business Wire • 09-13-2023
By Business Wire • 04-11-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.